![]() |
|
|
Vol. 290, Issue 3, 1250-1257, September 1999
Dependent1
Department of Pharmacology, Emory University, Atlanta, Georgia
(T.B.B., M.B.S., L.F., E.T.M.); Laboratory of Metabolism, National
Cancer Institute, National Institutes of Health, Bethesda, Maryland
(J.M.P., F.J.G.); and Centre du Medicament, Université de Nancy
I, Nancy, France (L.F.)
Administration of the bacterial endotoxin lipopolysaccharide (LPS)
causes induction of cytochrome P-450 (CYP) 4A mRNAs in rat liver
and kidney. Because induction of the CYP4A subfamily by chemicals
requires peroxisome proliferator-activated receptor-
(PPAR
), we
determined whether CYP4A induction by LPS also requires PPAR
by
comparing the responses of PPAR
-null (
/
) and wild-type (+/+)
mice. Renal expression of CYP4A10, CYP4A14, and acyl-CoA oxidase was
induced by LPS treatment in (+/+) mice, and these effects were absent
in the (
/
) mice. In contrast, hepatic expression of CYP4A10 was
down-regulated in the (+/+) animals, and no significant induction of
acyl-CoA oxidase or CYP4A14 was detected in liver. Expression of the
peroxisomal bifunctional enzyme was not significantly affected by LPS
treatment. These results indicate that PPAR
is activated in mouse
kidney after LPS treatment and that this leads to modulation of some
PPAR
-regulated genes. However, the species and tissue specificity of
these effects suggest that inflammatory pathways may modulate the
induction via PPAR
. Mice pair fed with LPS-treated mice showed no
induction of renal CYP4A10 or CYP4A14, indicating that renal CYP4A
induction during endotoxemia is not due to hypophagia. Down-regulation
of CYP2A5, CYP2C29, and CYP3A11 by LPS was attenuated or blocked in the
(
/
) mice, suggesting a role for PPAR
in CYP
down-regulation as well. Finally, we found that clofibrate caused an
acute induction of two hepatic acute-phase mRNAs that was only
partially dependent on PPAR
.
This article has been cited by other articles:
![]() |
T. Mori, H. Kondo, T. Hase, I. Tokimitsu, and T. Murase Dietary Fish Oil Upregulates Intestinal Lipid Metabolism and Reduces Body Weight Gain in C57BL/6J Mice J. Nutr., December 1, 2007; 137(12): 2629 - 2634. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Petrick and C. D. Klaassen Importance of Hepatic Induction of Constitutive Androstane Receptor and Other Transcription Factors That Regulate Xenobiotic Metabolism and Transport Drug Metab. Dispos., October 1, 2007; 35(10): 1806 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Hanniman, G. Lambert, Y. Inoue, F. J. Gonzalez, and C. J. Sinal Apolipoprotein A-IV is regulated by nutritional and metabolic stress: involvement of glucocorticoids, HNF-4{alpha}, and PGC-1{alpha} J. Lipid Res., November 1, 2006; 47(11): 2503 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kondo, Y. Minegishi, Y. Komine, T. Mori, I. Matsumoto, K. Abe, I. Tokimitsu, T. Hase, and T. Murase Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1092 - E1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Kupper, E. Gaquerel, E.-M. Boneberg, S. Morath, J.-P. Salaun, and P. Potin Early events in the perception of lipopolysaccharides in the brown alga Laminaria digitata include an oxidative burst and activation of fatty acid oxidation cascades J. Exp. Bot., June 1, 2006; 57(9): 1991 - 1999. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Richardson, M. Sherman, L. Antonovic, S. S. Kardar, H. W. Strobel, D. Kalman, and E. T. Morgan HEPATIC AND RENAL CYTOCHROME P450 GENE REGULATION DURING CITROBACTER RODENTIUM INFECTION IN WILD-TYPE AND TOLL-LIKE RECEPTOR 4 MUTANT MICE Drug Metab. Dispos., March 1, 2006; 34(3): 354 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Richardson, M. Sherman, D. Kalman, and E. T. Morgan EXPRESSION OF UDP-GLUCURONOSYLTRANSFERASE ISOFORM mRNAS DURING INFLAMMATION AND INFECTION IN MOUSE LIVER AND KIDNEY Drug Metab. Dispos., March 1, 2006; 34(3): 351 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Richardson and E. T. Morgan Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout Mice J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 703 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Teng and M. Piquette-Miller The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in Mice J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 841 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. t. Dieck, F. Doring, D. Fuchs, H.-P. Roth, and H. Daniel Transcriptome and Proteome Analysis Identifies the Pathways That Increase Hepatic Lipid Accumulation in Zinc-Deficient Rats J. Nutr., February 1, 2005; 135(2): 199 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Kim, K. Park, E. Kwak, E. Choi, S. Lee, J. Ham, H. Kang, J. M. Kim, S. Y. Hwang, Y.-Y. Kong, et al. Activating Signal Cointegrator 2 Required for Liver Lipid Metabolism Mediated by Liver X Receptors in Mice Mol. Cell. Biol., May 15, 2003; 23(10): 3583 - 3592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pan, Q. Xiang, S. Ball, J. Scatina, J. Kao, and J.-Y. Hong Lipopolysaccharide-Mediated Modulation of Cytochromes P450 in Stat1 Null Mice Drug Metab. Dispos., April 1, 2003; 31(4): 392 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Pass, W. Becker, R. Kluge, K. Linnartz, L. Plum, K. Giesen, and H.-G. Joost Effect of Hyperinsulinemia and Type 2 Diabetes-Like Hyperglycemia on Expression of Hepatic Cytochrome P450 and Glutathione S-Transferase Isoforms in a New Zealand Obese-Derived Mouse Backcross Population J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 442 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Akiyama, C. J. Nicol, C. Fievet, B. Staels, J. M. Ward, J. Auwerx, S. S. T. Lee, F. J. Gonzalez, and J. M. Peters Peroxisome Proliferator-activated Receptor-alpha Regulates Lipid Homeostasis, but Is Not Associated with Obesity. STUDIES WITH CONGENIC MOUSE LINES J. Biol. Chem., October 12, 2001; 276(42): 39088 - 39093. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cui, H. Kawashima, T. B. Barclay, J. M. Peters, F. J. Gonzalez, E. T. Morgan, and H. W. Strobel Molecular Cloning and Regulation of Expression of Two Novel Mouse CYP4F Genes: Expression in Peroxisome Proliferator-Activated Receptor alpha -Deficient Mice upon Lipopolysaccharide and Clofibrate Challenges J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 542 - 550. [Abstract] [Full Text] |
||||
![]() |
E. T. Morgan Regulation of Cytochrome P450 by Inflammatory Mediators: Why and How? Drug Metab. Dispos., March 1, 2001; 29(3): 207 - 212. [Abstract] [Full Text] |
||||
![]() |
S. R. Mitchell, M. B. Sewer, S. S. Kardar, and E. T. Morgan Characterization of Cyp4a Induction in Rat Liver by Inflammatory Stimuli: Dependence on Sex, Strain, and Inflammation-Evoked Hypophagia Drug Metab. Dispos., January 1, 2001; 29(1): 17 - 22. [Abstract] [Full Text] |
||||
![]() |
K. W. Renton and T. E. Nicholson Hepatic and Central Nervous System Cytochrome P450 Are Down-Regulated during Lipopolysaccharide-Evoked Localized Inflammation in Brain J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 524 - 530. [Abstract] [Full Text] |
||||
![]() |
A. P. Beigneux, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver J. Biol. Chem., May 19, 2000; 275(21): 16390 - 16399. [Abstract] [Full Text] [PDF] |
||||